IQVIA Holdings (MEX:IQV) Beta: 0.1785 (As of Jun. 24, 2026)


MEX:IQV IQVIA Holdings Inc MEX:IQV
76 GF Score
Price MXN3,000.00
GF Value MXN4,360.58
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is IQVIA Holdings Beta?

IQVIA Holdings MEX:IQV +3.84% 76 Beta is 0.1785 as of Jun. 24, 2026. GuruFocus rates MEX:IQV with a GF Score™ of 76/100 and a GF Value™ of MXN4,360.58 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), IQVIA Holdings's Beta is 0.1785.


IQVIA Holdings  (MEX:IQV) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


IQVIA Holdings Beta Related Terms


IQVIA Holdings Beta Historical Data

* Premium members only.

The historical data trend for IQVIA Holdings's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings Beta Chart

IQVIA Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.68 0.71 0.20

IQVIA Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.54 0.34 0.20 0.08

MEX:IQV vs NTRA, ILMN, MTD: Beta Comparison

For the Diagnostics & Research subindustry, IQVIA Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings Beta vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Beta distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Beta falls into.


MEX:IQV
76GF Score
IQVIA Holdings Inc MEX:IQV
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IQVIA Holdings Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.1785 mean?
IQVIA Holdings (MEX:IQV) has a Beta of 0.1785 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for IQVIA Holdings and its competitors.
Is IQVIA Holdings' Beta too high?
IQVIA Holdings' current Beta is 0.1785. Overall, IQVIA Holdings has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' Beta compare to NTRA and ILMN?
IQVIA Holdings' Beta of 0.1785 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Diagnostics & Research company?
A good Beta depends on the Medical Diagnostics & Research industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for IQVIA Holdings and its competitors. IQVIA Holdings's current Beta is 0.1785. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (MEX:IQV) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN4,360.58, compared to a current price of MXN3,000.00 — trading 31.2% below its estimated fair value. The current Beta is 0.1785. IQVIA Holdings' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For IQVIA Holdings (MEX:IQV), the current Beta is 0.1785 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IQVIA Holdings (MEX:IQV) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of MXN3,000.00 is trading 31.2% below its estimated GF Value™ of MXN4,360.58. GuruFocus considers IQVIA Holdings to be Significantly Undervalued.

Key valuation signals for MEX:IQV:

  • Beta: 0.1785
  • GF Value™: MXN4,360.58 vs. price of MXN3,000.00 (31.2% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the MEX:IQV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
76GF Score

Get the complete analysis for MEX:IQV

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,000.00
Price
MXN4,360.58
GF Value